Hola,
¿eres nuevo aquí?

Registrate y conecta tu empresa con financiación pública, partners y proyectos.

SCIENSC

Financiado

Identification of Transiently Formed Immune-Endogenous Neural Stem Cell Niches i...

Identification of Transiently Formed Immune-Endogenous Neural Stem Cell Niches in Spinal Cord Injury Despite endogenous neural stem cells (eNSCs) being present in the adult mammalian central nervous system (CNS), their neuronal potential upon injury is rarely achieved in the brain and never in the spinal cord (SC) environment. Th... ver más

31/08/2025

223K€

Presupuesto del proyecto: 223K€

Líder del proyecto

KAROLINSKA INSTITUTET No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2022-07-18

Línea de financiación objetivo El proyecto se financió a través de la siguiente ayuda:

HORIZON-MSCA-2021-PF-01-01: MSCA Postdoctoral Fellowships 2021

I+D

Cerrada hace 3 años

0% 100%

1 Participantes

222.73K€ | Lider

Proyectos interesantes

SAF2009-12495 RESPUESTA MEDULAR AL TRASPLANTE DE GLIA ENVOLVENTE Y DE CELU... 182K€ Cerrado

PID2019-108496RA-I00 TERAPIA EPIGENETICA PARA PROMOVER LA RECUPERACION FUNCIONAL... 143K€ Cerrado

SAF2013-48431-R PARTICIPACION DE LOS RECEPTORES DEL ACIDO LISOFOSFATIDICO EN... 157K€ Cerrado

BFU2011-27966 GENES IMPLICADOS EN EL DAÑO MEDULAR Y EN SU REPARACION MEDIA... 103K€ Cerrado

PID2019-110195RB-I00 PAPEL FUNCIONAL DE LA SEÑALIZACION GLUTAMATERGICA EN GLIA NG... 131K€ Cerrado

SAF2010-17851 ACTIVACION DE LOS PROGRAMAS DE RESOLUCION DE LA INFLAMACION... 109K€ Cerrado

Últimas noticias

29-11-2024: IDAE En las últimas 48 horas el Organismo IDAE ha otorgado 4 concesiones

29-11-2024: ECE En las últimas 48 horas el Organismo ECE ha otorgado 2 concesiones

29-11-2024: CMVAMADRID En las últimas 48 horas el Organismo CMVAMADRID ha otorgado 37 concesiones

Duración del proyecto: 37 meses Fecha Inicio: 2022-07-18
Fecha Fin: 2025-08-31

Líder del proyecto

KAROLINSKA INSTITUTET

TRL 4-5

Presupuesto del proyecto 223K€

Descripción del proyecto Despite endogenous neural stem cells (eNSCs) being present in the adult mammalian central nervous system (CNS), their neuronal potential upon injury is rarely achieved in the brain and never in the spinal cord (SC) environment. This makes widespread SC injuries (SCIs) especially challenging to treat. Even though SC eNSCs give rise to astrocytes, oligodendrocytes, and neurons in vitro, they almost exclusively generate glial scar-forming astrocytes, seldom myelinating oligodendrocytes, and never neurons in mammalian models. We still do not know the exact SC niche cues preventing eNSCs from efficiently assuming oligodendrocyte and neuronal fates, averting a functional SC healing. Notably, SCI induces a vast immune response and I hypothesise that immune cells that are responsive to the SCI, contribute to eNSC niche formation, where they can exert an effect on eNSC regulation. I will investigate this by unravelling (O1) temporal, heterogenous immune responses to the SCI and (O2) their spatial interplay with the eNSCs using advanced methodologies, such as spectral flow cytometry and spatial transcriptomics. This will enable me to identify which of these immune cells affect eNSC gene regulatory networks leading to instigation of astrocyte but not oligodendrocyte or neuronal fates. Finally, (O3) I will identify SCI-specific enhancer elements of the immune cells of interest by comparing chromatin signatures of these immune cell types located across different tissues. This knowledge will present a ‘divide and conquer’ opportunity – to compartmentalise and disconnect immune system across different tissues enabling a targeted immune cell manipulation specifically within the SCI environment. The long-term outcome of this project will help the design of enhancer-based immuno-modulatory therapies to dictate eNSC fates and generate oligodendrocytes and neurons in vivo leading to a functional SCI recovery.

Conecta tu I+D

Entra hoy

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores